Transcription factor A, mitochondrial promotes lymph node metastasis and lymphangiogenesis in epithelial ovarian carcinoma
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Mitochondrial Transcription Factor A (TFAM) is upregulated in epithelial ovarian cancer (EOC), promoting tumor growth and metastasis. Silencing TFAM inhibits EOC cell proliferation and induces apoptosis, suggesting TFAM as a potential therapeutic target.
Area Of Science
- Oncology
- Mitochondrial Biology
- Gene Expression
Background
- Mitochondria are crucial in cancer progression, but their specific roles in epithelial ovarian cancer (EOC) are not fully understood.
- Investigating mitochondrial gene mechanisms in EOC is essential for understanding disease progression.
Purpose Of The Study
- To identify candidate mitochondrial genes involved in EOC.
- To elucidate the biological functions and mechanisms of these genes in EOC progression.
Main Methods
- Utilized Gene Expression Omnibus RNA-seq data for bioinformatics analysis to identify differentially expressed mitochondrial genes in EOC.
- Employed immunohistochemistry to assess Transcription Factor A, mitochondrial (TFAM) expression in EOC tissues.
- Conducted in vitro assays to determine the functional role of TFAM in EOC cells.
Main Results
- Identified TFAM, HSPE1, and CYC1 as significantly upregulated mitochondrial genes in EOC, correlating with poor prognosis.
- TFAM expression was elevated in EOC tissues and linked to advanced clinical stage, lymph node metastasis, and reduced overall survival.
- Silencing TFAM suppressed EOC cell proliferation and migration while promoting apoptosis.
Conclusions
- TFAM enhances EOC cell secretion of VEGF-A, VEGF-C, and VEGF-D, promoting lymphangiogenesis and metastasis.
- These findings offer new insights into TFAM's role in EOC, highlighting its potential as a diagnostic and therapeutic target.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...